Tag: FDA bioequivalence

FDA Bioequivalence Standards for NTI Drugs: Special Requirements Explained

The FDA requires stricter bioequivalence standards for NTI drugs like warfarin, digoxin, and phenytoin, with tighter limits (90-111%) and scaled testing to ensure patient safety. These rules prevent dangerous variations in generic versions.